Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose-response meta-analysis.
Ioannis BellosSmaragdi MarinakiPagona LagiouVassiliki BenetouPublished in: International urology and nephrology (2024)
This study suggests that high serum galectin-3 levels are associated with greater all-cause mortality risk among patients on maintenance hemodialysis. Preliminary cross-sectional evidence indicates that serum galectin-3 may be associated with arterial stiffness and left ventricular dysfunction.
Keyphrases
- cardiovascular disease
- systematic review
- left ventricular
- cross sectional
- blood pressure
- cardiovascular events
- type diabetes
- oxidative stress
- chronic kidney disease
- acute myocardial infarction
- randomized controlled trial
- risk factors
- hypertrophic cardiomyopathy
- mitral valve
- coronary artery disease
- left atrial
- atrial fibrillation
- end stage renal disease
- insulin resistance
- percutaneous coronary intervention
- aortic stenosis
- ejection fraction